Cite

    Liu, K. et al. (2018). Small ubiquitin‐like modifier/sentrin‐specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non‐small cell lung cancer. Journal of clinical laboratory analysis. 32 (9), p. n/a. [Online].